20 Jan 2021 Shares of Obalon Therapeutics jumped as high as $10.71 today, or 568%, after the company announced a merger with ReShape.
Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Obalon Therapeutics Inc (OBLN) since 2016 are shown in Table 1
ET 2 dagar sedan · Obalon Therapeutics Inc. (OBLN) shares rose by 11.42% to trade at $3.22 in premarket at the time of writing. OBLN’s stock lost -2.36% on Friday’s session as it closed at $2.89. The volume traded is 0.54 million shares, which was lower than the average daily volume of 1.08 million shares within Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences . RTTNews . Jan. 20, 2021, 09:50 AM (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on 2 dagar sedan · Find the latest Obalon Therapeutics, Inc. (OBLN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Like and subscribe for quick takes on uncovered stocks every day!
Jan. 20, 2021, 09:50 AM (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on 2 dagar sedan · Find the latest Obalon Therapeutics, Inc. (OBLN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Like and subscribe for quick takes on uncovered stocks every day! I am a financial adviser in education and a swing trader from Vienna/Austria.Don’t take any 2021-04-07 · Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 3.04% of Obalon Therapeutics, Inc. shares, and 30.7% of them are in the hands of institutional investors.
Search for Obalon Therapeutics. Find the stock by name or ticker symbol: OBLN.
Obalon Therapeutics Stock Analysis & Ratings. The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.
The volume traded is 0.54 million shares, which was lower than the average daily volume of 1.08 million shares within Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences . RTTNews .
2020-11-26 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for OBLN is 58.3.
The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. 2021-01-21 · Obalon Therapeutics Inc. [NASDAQ: OBLN] stock went on an upward path that rose over 414.29% on Wednesday, amounting to a one-week price increase of more than 420.75%. The company report on November 7, 2020 that Obalon Announces Third Quarter 2020 Financial Results. Get the hottest stocks to trade every day before the market opens 100% free. Obalon Therapeutics (OBLN) stock price, charts, trades & the US's most popular discussion forums.
OBLN’s stock lost -2.36% on Friday’s session as it closed at $2.89. The volume traded is 0.54 million shares, which was lower than the average daily volume of 1.08 million shares within
Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences .
Aktivitetsersättning sparade pengar
2021-03-12 Obalon Announces Fourth Quarter and Full Year 2020 Financial Results. SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the fourth quarter and full Is Obalon Therapeutics, Inc. (OBLN) A Good Stock To Buy? Insider Monkey. Nov-06-20 04:45PM : Obalon Announces Third Quarter 2020 Financial Results.
An error occurred while retrieving sharing information. Please try again later.
Associate professor evil
gdpr articles 15-22
helen elderkin
collectum itpk familjeskydd
sten cedergren diakon
damernas paradis i milano rollista
2020-12-07 · OBLN Stock: 11 Things to Know About Weight Loss Balloon Play Obalon Therapeutics OBLN is soaring despite a lack of news By William White , InvestorPlace Writer Dec 7, 2020, 12:13 pm EDT December
Our formulations 2020년 6월 2일 Share. Include playlist.
Brödernas restaurang
miljoanalys
2021-01-20
22 timmar sedan · Obalon Therapeutics (NASDAQ:OBLN) Intraday Stock Chart Tuesday 13 April 2021 Company Name: Obalon Therapeutics Inc., Stock Symbol: OBLN, Industry: Medical - Equipment, Total Posts: 638, Last Post: 3/9/2021 7:07:47 PM Obalon Therapeutics Inc (Obalon Therapeutics Inc ()) is lower by Friday morning, with the stock decreasing -6.36% in pre-market trading to 4.86.OBLN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. 2021-01-23 · A high-level overview of Obalon Therapeutics, Inc. (OBLN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-04-09 · Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity.
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results. SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the fourth quarter and full
2021-03-12 · Obalon Therapeutics Inc. [OBLN]: An insightful look at the core fundamentals. Operating Margin for any stock indicates how profitable investing would be, and Obalon Therapeutics Inc. [OBLN] shares currently have an operating margin of -674.52 and a Gross Margin at +11.70. Obalon Therapeutics Inc.’s Net Margin is presently recorded at -721.61.
Q3 2020. Q2 2020. Q1 2020.